Eli Lilly Introduces Weight-Loss Drug Mounjaro in India Eli Lilly, the renowned US pharmaceutical company, has launched its highly anticipated weight-loss and diabetes management drug, Mounjaro (tirzepatide), in India. Approved by the Central Drugs Standard Control Organization (CDSCO), Mounjaro is now available as a groundbreaking treatment for obesity and Type 2 diabetes. Affordable Pricing and…